ArticleCJEM2026
Rapid development of a dedicated emergency department follow-up clinic during a large pediatric Shiga toxin-producing E. coli outbreak.
Article in CJEM, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo describe the rapid development, implementation, and outcomes of a dedicated pediatric Shiga toxin-producing Escherichia coli follow-up clinic during a large outbreak, and to identify operational lessons relevant to future surge events.
methodsDuring the 2023 Calgary daycare-associated STEC outbreak, the Alberta Children's Hospital activated an emergency command structure and rapidly established a follow-up clinic for the anticipated surge of children requiring daily assessment and laboratory monitoring. New clinic space was developed by repurposing conference rooms into clinical spaces with workflows designed to support patient flow, safety, and infection prevention. Staffing was achieved through multidisciplinary redeployment and voluntary additional shifts and supported by rapid training and standardized clinical care. Processes were refined using Plan-Do-Study-Act cycles informed by frontline feedback, conversations with families, and direct observation. Operational data were collected and staff feedback was obtained through a post-outbreak survey.
resultsAfter 2 days of treating patients in a modified pre-existing clinic space, the dedicated clinic opened in repurposed conference room space. Between September 6 and 21, 133 patients accounted for 328 visits that would have otherwise occurred in the ED. The median daily visit volume was 22 (range 1-44), and the median number of visits per patient was 2 (range 1-7). Laboratory testing occurred in 97.6% of visits, 3.5% involved intravenous fluid administration, and 2.1% of visits led to admission. No significant adverse events occurred among discharged patients. Survey respondents shared insights for future preparedness, and 85% rated clinic effectiveness at 8/10 or higher.
conclusionRapid expansion of ambulatory capacity during outbreaks can be achieved through coordinated redesign of space, staffing, systems, and support services. In this model, early command structure activation, repurposing of non-clinical space, standardized protocols, and broad stakeholder engagement enabled safe care while preserving ED capacity. These transferable principles offer a practical approach for managing future outbreaks.
Indexed as
Identifiers
42786413What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.